Skip to content

CYTK

Cytokinetics, Incorporated

Key figures

MetricLast 12 months5-year CAGR
Revenue$113M+9.5%
Operating income−$708M—
Net income−$778M—
EPS−$6.05—
Free cash flow−$589M—